Evidence map›Paper›PMID 10880439›Full record

ArticleThe EMBO journal2000

Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin.

R Schönherr, K Löber, S H Heinemann

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Fentanyl blockade of KThe Journal of physiology · 2026
    Article
  6. Article
  7. The Role of the Swollen State in Cell Proliferation.The Journal of membrane biology · 2025
    Review
  8. Article
  9. Article
  10. Voltage-sensor movements in the Eag Kv channel under an applied electric field.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Potassium and Calcium Channel Complexes as Novel Targets for Cancer Research.Reviews of physiology, biochemistry and pharmacology · 2022
    Article
  13. Article
  14. Dynamic NaeLife · 2021
    Article
  15. NovelGenes · 2021
    Article
  16. Membrane Transporters and Channels in Melanoma.Reviews of physiology, biochemistry and pharmacology · 2021
    Review
  17. Review
  18. Article
  19. hERG Function in Light of Structure.Biophysical journal · 2020
    Review
  20. Atomistic Insights of Calmodulin Gating of Complete Ion Channels.International journal of molecular sciences · 2020
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R SchönherrArbeitsgruppe Molekulare und zelluläre Biophysik, am Klinikum der Friedrich-Schiller-Universität Jena, Drackendorfer Strabetae 1, D-07747 Jena, Germany.
K Löber
S H Heinemann
Friedrich Schiller University Jena · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracellular Ca(2+) inhibits voltage-gated potassium channels of the ether à go-go (EAG) family. To identify the underlying molecular mechanism, we expressed the human version hEAG1 in Xenopus oocytes. The channels lost Ca(2+) sensitivity when measured in cell-free membrane patches. However, Ca(2+) sensitivity could be restored by application of recombinant calmodulin (CaM). In the presence of CaM, half inhibition of hEAG1 channels was obtained in 100 nM Ca(2+). Overlay assays using labelled CaM and glutathione S-transferase (GST) fusion fragments of hEAG1 demonstrated direct binding of CaM to a C-terminal domain (hEAG1 amino acids 673-770). Point mutations within this section revealed a novel CaM-binding domain putatively forming an amphipathic helix with both sides being important for binding. The binding of CaM to hEAG1 is, in contrast to Ca(2+)-activated potassium channels, Ca(2+) dependent, with an apparent K(D) of 480 nM. Co-expression experiments of wild-type and mutant channels revealed that the binding of one CaM molecule per channel complex is sufficient for channel inhibition.

Indexed as

Cation Transport ProteinsDNA-Binding ProteinsPotassium Channel BlockersPotassium Channels, Voltage-GatedTrans-ActivatorsAmino Acid SequenceAnimalsBinding SitesCalciumCalmodulinERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsHumansIon Channel GatingMolecular Sequence DataPotassium ChannelsCalciumCalmodulinCation Transport ProteinsDNA-Binding ProteinsERG1 Potassium ChannelERG protein, humanEther-A-Go-Go Potassium ChannelsKCNH1 protein, humanKCNH6 protein, humanPotassium Channel BlockersPotassium ChannelsPotassium Channels, Voltage-GatedRecombinant ProteinsTrans-ActivatorsTranscriptional Regulator ERG

Identifiers

PMID10880439
PMCPMC313935
OpenAlexW2094821336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.